Viad - VVI Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Viad in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" VVI shares.
View VVI analyst ratings or view top-rated stocks.

3 brokerages have issued 1-year price targets for Viad's stock. Their VVI share price forecasts range from $42.00 to $45.00. On average, they anticipate the company's stock price to reach $43.00 in the next year. This suggests a possible upside of 44.5% from the stock's current price.
View analysts price targets for VVI or view top-rated stocks among Wall Street analysts.

Viad's stock was trading at $42.79 on January 1st, 2022. Since then, VVI shares have decreased by 30.5% and is now trading at $29.76.
View the best growth stocks for 2022 here.

Viad saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 399,300 shares, a decrease of 20.4% from the October 31st total of 501,500 shares. Based on an average daily trading volume, of 88,300 shares, the days-to-cover ratio is presently 4.5 days. Approximately 2.0% of the company's stock are short sold.
View Viad's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our VVI earnings forecast.

Viad Corp (NYSE:VVI) released its quarterly earnings data on Thursday, November, 4th. The business services provider reported $0.58 earnings per share for the quarter, missing the consensus estimate of $1.75 by $1.17. The business services provider had revenue of $233.60 million for the quarter, compared to analysts' expectations of $150.27 million. Viad had a trailing twelve-month return on equity of 18.08% and a net margin of 0.79%. During the same period last year, the firm posted ($0.81) EPS.

5 employees have rated Viad Chief Executive Officer Steve W. Moster on Glassdoor.com. Steve W. Moster has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Viad investors own include Pfizer (PFE), AbbVie (ABBV), Verizon Communications (VZ), Dynavax Technologies (DVAX), Enbridge (ENB), Procter & Gamble (PG), QUALCOMM (QCOM), Trevena (TRVN), Universal Technical Institute (UTI) and VBI Vaccines (VBIV).

Viad trades on the New York Stock Exchange (NYSE) under the ticker symbol "VVI."

Viad's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.94%), Victory Capital Management Inc. (11.55%), Vanguard Group Inc. (6.48%), Allspring Global Investments Holdings LLC (6.27%), Blue Grotto Capital LLC (5.37%) and River Road Asset Management LLC (4.81%). Insiders that own company stock include Andrew B Benett, David W Barry, Ellen M Ingersoll, Jeffrey A Stelmach, Joshua Schechter and Steven W Moster.
View institutional ownership trends.

Shares of VVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VVI stock can currently be purchased for approximately $29.76.

Viad (NYSE:VVI) has a market capitalization of $615.14 million and generates $507.34 million in revenue each year. The business services provider earns $-92,650,000.00 in net income (profit) each year or ($0.74) on an earnings per share basis.

The company employs 3,512 workers across the globe.

Viad's mailing address is 1850 NORTH CENTRAL AVENUE SUITE 1900, PHOENIX AZ, 85004. The official website for the company is www.viad.com. The business services provider can be reached via phone at (602) 207-1000, via email at investorrelations@viad.com, or via fax at 602-207-5834.